Objectives: This paper aims to report on a case in which re-challenging with clozapine in combination with lithium in a patient who developed neutropenia was carried out. Methods: The patient was treated with clozapine for treatment-resistant schizophrenia. After five weeks he showed much improvement but developed neutropenia. Withdrawal of clozapine brought on a relapse of psychotic symptoms. Subsequently, clozapine was reintroduced along with Lithium. The neutrophil count was monitored closely. Results: The neutrophil and white blood cell count were noted to return to normal upon re-challenging, and the patient’s clinical condition also improved. Conclusion: Simultaneous administration of lithium and clozapine to patients experiencing neu...
Background Data on the haematological outcomes of patients who continue clozapine treatment followi...
Background: In most countries, clozapine can only be prescribed with regular monitoring of white blo...
Background and Objectives: Clozapine is the only antipsychotic approved for treatment-resistant schi...
Objective: Clozapine remains the most effective intervention for treatment resistant schizophrenia; ...
Clozapine is the only drug with confirmed efficacy for refractory schizophrenia; however, its use is...
Addition of lithium therapy in a patient with persistent neutropenia triggered with antipsychotics D...
This case outlines recurrent neutropenia after fourteen years of successful clozapine use. The patie...
Abstract Background Clozapine use is complicated by an increased risk of hematological adverse effec...
Objective: To report and review the use of cytokines for the treatment of clozapine-induced neutrope...
This letter describes the 2-year follow-up of a 7-year-old girl with very-early-onset schizophrenia ...
Objective To review recent work on the haematological toxicity of clozapine and some other drugs use...
Abstract: OBJECTIVE: Certain patients with treatment-refractory schizophrenia may be rechallenged wi...
Clozapine is the antipsychotic of choice in the management of treatment resistant schizophrenia. Neu...
Several case reports described neurotoxic side-effects in the course of a combined clozapine-lithium...
Atypical neuroleptics are increasingly used in the treatment of bipolar and schizoaffective disorder...
Background Data on the haematological outcomes of patients who continue clozapine treatment followi...
Background: In most countries, clozapine can only be prescribed with regular monitoring of white blo...
Background and Objectives: Clozapine is the only antipsychotic approved for treatment-resistant schi...
Objective: Clozapine remains the most effective intervention for treatment resistant schizophrenia; ...
Clozapine is the only drug with confirmed efficacy for refractory schizophrenia; however, its use is...
Addition of lithium therapy in a patient with persistent neutropenia triggered with antipsychotics D...
This case outlines recurrent neutropenia after fourteen years of successful clozapine use. The patie...
Abstract Background Clozapine use is complicated by an increased risk of hematological adverse effec...
Objective: To report and review the use of cytokines for the treatment of clozapine-induced neutrope...
This letter describes the 2-year follow-up of a 7-year-old girl with very-early-onset schizophrenia ...
Objective To review recent work on the haematological toxicity of clozapine and some other drugs use...
Abstract: OBJECTIVE: Certain patients with treatment-refractory schizophrenia may be rechallenged wi...
Clozapine is the antipsychotic of choice in the management of treatment resistant schizophrenia. Neu...
Several case reports described neurotoxic side-effects in the course of a combined clozapine-lithium...
Atypical neuroleptics are increasingly used in the treatment of bipolar and schizoaffective disorder...
Background Data on the haematological outcomes of patients who continue clozapine treatment followi...
Background: In most countries, clozapine can only be prescribed with regular monitoring of white blo...
Background and Objectives: Clozapine is the only antipsychotic approved for treatment-resistant schi...